Redox Srl
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Italy
- Registered address
- Via Gian Battista Stucchi 62/26, Monza, 20900, Italy (ITA)
- Operations here
- analysis
- FDA identifiers
- FEI 3006720740 · DUNS 439198391
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-03-08
- VAIDrug Quality Assurance2019-05-24
- NAIUnapproved and Misbranded Drugs2015-02-20
- VAIDrug Quality Assurance2015-02-20
- VAIDrug Quality Assurance2011-09-28
Drugs this plant is listed as making
3 distinct drugs across 5 products name this site in their FDA label.
- minocycline hydrochlorideMelinta Therapeutics, LLC
- tisotumab vedotinSeagen Inc.
- TrimipramineBreckenridge Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.